View Clinical Trial (Medical Research Study)

Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer - NCT00732173-44024(Clinical Trial 235480)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Cleveland
State:  
OH
Zip Code: 44024
Conditions: Endometrial Cancer
Purpose: RATIONALE: Participating in a diet and exercise program may improve the quality of life of overweight and obese patients who are in remission from endometrial cancer. PURPOSE: This randomized phase I trial is studying an exercise and healthy diet program to see how well it works compared with standard care in patients in remission from stage I or stage II endometrial cancer.
Study summary: OBJECTIVES: - To expand and refine a previous pilot study of a behavioral, lifestyle-change education intervention for use in overweight and obese patients in remission from endometrial carcinoma. - To determine the potential effects and variation of each regimen in these patients. - To explore potential mediators (self-efficacy, depression) and moderators (body mass index) of healthful dietary and exercise behaviors. OUTLINE: Patients are stratified according to body mass index (25.0-39.9 vs ≥ 40) and randomized to 1 of 2 intervention arms. - Arm I: Patients receive a lifestyle intervention, "Survivors of Uterine Cancer Empowered by Exercise and Healthy Diet (SUCCEED)", on a group and individual basis consisting of nutrition, exercise, and behavioral modification counseling from a physician, psychologist, registered dietitian, and physical therapist. Sixteen group sessions will be conducted (10 weekly, 6 bi-weekly) for 6 months. Weight and body mass index, satisfaction with study treatment, and exercise/activity logs are assessed weekly and biweekly. Patients receive additional feedback and support during the weeks not met in a group, including newsletters and telephone and e-mail contact. - Arm II (control): Patients receive usual care informational brochures, but no lifestyle counseling, related to weight loss, physical activity, and nutrition. Patients undergo physician counseling sessions at baseline and 3, 6, and 12 months. Patients are assessed by weight, anthropometric measures, and body mass index; biomarkers; body composition by dual-energy x-ray absorptiometry/densitometry (DEXA); co-morbidities by the Charlson co-morbidity score; depression by the Beck Depression Inventory (BDI); eating patterns by the Three-Factor Eating Inventory (EI); exercise/physical activity by Leisure Score Index (LSI) and pedometer step count; nutrient intake by 24-hour recall; quality of life by the Functional Assessment of Cancer Therapy-General (FACT-G) and Short-form Medical Outcomes (SF-36); and self-efficacy by the Self-Efficacy Questionnaire (SEQ) and the Weight Efficacy Life-Style (WEL).
Criteria: DISEASE CHARACTERISTICS: - Histologically confirmed stage I or II (early) endometrial carcinoma - Diagnosed within the past 3 years - Underwent prior surgery consisting of a total abdominal hysterectomy and bilateral salpingo-oophorectomy - No evidence of disease PATIENT CHARACTERISTICS: - ECOG performance status 0-2 - BMI ≥ 25 (overweight/obese) - Medical clearance from primary care physician - Approved for contact by treating gynecologic oncologist - At least a 6th-grade reading level to complete significant reading and homework - No severe psychiatric illness (e.g., schizophrenia, bipolar disorder) or major depression (Beck Depression Inventory > 29) that needs more aggressive, problem-focused interventions - No dementia or cognitive deficits - No pre-existing medical conditions that would be a barrier for participation in unsupervised walking - No participation in a structured weight loss or exercise program in the past 6 months - Must agree to and be available for longitudinal follow-up assessments - Non-English speakers may bring an English-speaking person to all group sessions and visits PRIOR CONCURRENT THERAPY: - See Disease Characteristics
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: June 7, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.